Amgen and AstraZeneca's Tezspire showed significant reductions in nasal polyp severity, congestion, and surgery need in CRSwNP patients in the Phase 3 WAYPOINT trial.

Discover eight promising respiratory disease companies advancing their novel therapies through clinical trials in 2025.

chronic obstructive pulmonary disease (COPD), and ... How a New Gut Microbe Drives the Gut-Lung Axis Dec. 19, 2024 — A team has discovered a new communication pathway between the gut and lung.

I do all my own housework, shopping, and laundry,” says Owens, who has chronic obstructive pulmonary disease (COPD). “I try to stay as active as I can, so I can continue to care for myself.